This research characterizes the current state of scientific investigation into the world of blindness: virtually all human trials are far down the road, and any findings, so far, pertain only to the ...

Nanoscope Therapeutics is back with more data assessing its gene therapy that uses light-sensitive molecules to treat retinal disease. With data demonstrating vision improvement in hand, the biotech ...

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging advances, from gene editing and stem cells to microchips and laser-based ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related ...

Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining’ the eyes for people who experience a loss of vision after ...

Jace, now 6, was born with a rare genetic condition that causes blindness Courtesy of Moorfields Hospital A Connecticut boy is among four children all born with severe childhood blindness who gained ...